1. Immunogenicity of hepatitis A vaccination in decompensated cirrhotic patients;Arguedas;Hepatology,2001
2. Hepatitis A vaccine for immunosuppressed patients with rheumatoid arthritis: A prospective, open-label, multi-centre study;Askling;Travel Medicine and Infectious Disease,2014
3. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts;Baba;Journal of Clinical & Laboratory Immunology,1993
4. Predicted 30-year protection after vaccination with an aluminum-free virosomal hepatitis A vaccine;Bovier;Journal of Medical Virology,2010
5. CDC. 2015 Epidemiology and prevention of vaccine-preventable disease. Hepatitis A 13th edn. https://www.cdc.gov/vaccines/pubs/pinkbook/hepa.html: Centers for Disease Control and Prevention; 135–148.